speaker-photo

Dr. Shadi Khayat

panellist

Associate Professor of Medicine and oncology
Consultant medical oncology
King Abdulaziz University

9:00-09:45

Friday 3-5-2024 Day 1

Advanced HER2-positive/HER2-low breast cancer

Patient with brain metastasis and stable extracranial disease:  when to change antiHER2-based therapy
Patient with active brain metastasis: locoregional therapy vs systemic therapy
Patient with active brain metastasis:  T-DXd  vs.
tucatinib-based therapy
Can we use TDM1 after T-DXd 
Role of repeated biopsies to guide ADCs in HER2-low BC

Moderator:  Shereef Elsamany

Panel: